Overview of the clinical pharmacokinetics of eldecalcitol, a new active vitamin D3 derivative

Japanese Pharmacology and Therapeutics

Volumn 39, Issue 3, 2011, Pages 261-274

  Abe, Masaichi ^a   Tsuji, Naoki ^a   Takahashi, Fumiaki ^a   Tanigawara, Yusuke ^b  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Active vitamin D3; Edirol; Eldecalcitol; Osteoporosis; Pharmacokinetics

Indexed keywords

ALFACALCIDOL; COLECALCIFEROL; CYTOCHROME P450 3A4; ELDECALCITOL; PLACEBO; SIMVASTATIN;

AGE DISTRIBUTION; AREA UNDER THE CURVE; BIOEQUIVALENCE; BONE METABOLISM; CLINICAL TRIAL; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG PROTEIN BINDING; FOOD; FOOD DRUG INTERACTION; HUMAN; HUMAN EXPERIMENT; LIVER DYSFUNCTION; LIVER FUNCTION; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; OSTEOPOROSIS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEX DIFFERENCE; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 79955439317     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (8)

1. 3 analogues bearing a hydroxyalkoxy group at the 2β-position. Chem Pharm Bull (Tokyo) 1993 ; 41 (6) : 1111-3.
2. 3(Eldecalcitol), increases bone mass by stimulating the bone formation in normal and ovariectomized rats. Calcif Tissue Int 1994 ; 54 (2) : 142-9. (Pubitemid 24046725)
3. 3 and a vitamin D derivative (Eldecalcitol) in normal rats [in Japanese]. Osteoporosis Japan 1993 ; 1 (1) : 22-7.
4. Miyata K, Ohba Y, Abe M, Terao K, Kawanishi T, Ohnishi A. Effects of eldecalcitol on the pharmacokinetics of the CYP3A4 substrate, simvastatin : double blind, randomized, placebo-controlled, parallel group comparative study in healthy male volunteers. Jpn Pharmacol Ther 2011 ; 39 (3) : 275-85.
5. Miyata K, Abe M, Terao K, Kawanishi T, Tsuji N, Shiraki M, et al. Pharmacokinetics of eldecalcitol in primary osteoporosis patients : randomized, double-blind, multicentre, long-term phase III clinical study. Jpn Pharmacol Ther 2011 ; 39 (3) : 299-307.
6. Ikeda Y, Kumagai Y, Arinaga T, Sata M, Hiroki T, Miyata K, et al. Open-label, multicentre, single dose study of eldecalcitol pharmacokinetics in patients with impaired liver function. Jpn Pharmacol Ther 2011 ; 39 (3) : 287-97.
7. 3. Mol Pharmacol 1997 ; 51 : 741-54. (Pubitemid 27224679)
8. 3. Mol Pharmacol 2001 ; 60 : 1399-406. (Pubitemid 33144911)